Hm Payson & CO Zai Lab LTD Transaction History
Hm Payson & CO
- $5.79 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding ZLAB
# of Institutions
146Shares Held
53MCall Options Held
103KPut Options Held
439K-
Wellington Management Group LLP Boston, MA6.66MShares$231 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X06.57MShares$228 Million0.09% of portfolio
-
Capital World Investors Los Angeles, CA6.43MShares$223 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.17MShares$110 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$86.9 Million1.07% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.39B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...